Close Menu

NEW YORK (360Dx) – Clearbridge Health Limited said today that it has entered into an exclusive partnership with Hunan, China's Agen Medicine Laboratory Technology Company, under which it will provide the firm with its ClearCell FX1 System for circulating tumor cell enrichment, offer training and assistance in Agen's development of laboratory developed tests, and then market those tests in China.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.